Login / Signup

First field efficacy trial of the ChAd63 MVA ME-TRAP vectored malaria vaccine candidate in 5-17 months old infants and children.

Alfred B TionoIssa NébiéNicholas AnagnostouAboubacar S CoulibalyGeorgina BowyerErika LamEdith C BougoumaAlphonse OuedraogoJean Baptist B YaroAïssata BarryRachel RobertsTommy RamplingCarly BlissSusanne HodgsonAlison LawrieAmidou OuedraogoEgeruan Babatunde ImoukhuedeKatie J EwerNicola K ViebigAmidou DiarraOdile LeroyPhilip BejonAdrian V S HillSodiomon B Sirima
Published in: PloS one (2018)
ClinicalTrials.gov NCT01635647. Pactr.org PACTR201208000404131.
Keyphrases
  • young adults
  • study protocol
  • phase iii
  • clinical trial
  • plasmodium falciparum
  • phase ii
  • randomized controlled trial
  • open label
  • placebo controlled